Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: RBP-CRISPR Plasmid data of "In vivo CRISPR screen identifies SNRPC as a regulator for facilitating triple-negative breast cancer progression"

PROVIDER: PRJNA944405 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23851807_1.fastq.gz	Fastqsanger.gz
	SRR23851807_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Project description:RBP-CRISPR data of "In vivo CRISPR screen identifies SNRPC as a regulator for facilitating triple-negative breast cancer progression"

| PRJNA943113 | ENA

Project description:In vivo CRISPR screen identifies SNRPC as a regulator for facilitating triple-negative breast cancer progression

| PRJNA922615 | ENA

In vivo CRISPR screen identifies SNRPC as a regulator for facilitating triple-negative breast cancer progression

Project description:In vivo CRISPR screen identifies SNRPC as a regulator for facilitating triple-negative breast cancer progression

| PRJNA943537 | ENA

Project description:CHIP-seq data of Project identifying SNRPC as a regulator for facilitating triple-negative breast cancer progression

| PRJNA931800 | ENA

Project description:SNRPC promotes triple negative breast cancer progression partially by enhancing TNFAIP2 expression

| PRJNA888951 | ENA

In vivo CRISPR screen identifies SNRPC as a regulator for facilitating triple-negative breast cancer progression [RNA-Seq]

Project description:In this study, we employed an in vivo CRISPR screening and a TNBC progression model to identify potentially oncogenic RBPs. We identified the small nuclear ribonucleoprotein polypeptide C (SNRPC), a subunit of the U1 small nuclear ribonucleoprotein particle (U1 snRNP), as a key modulator involved in TNBC progression. SNRPC was frequently upregulated and relevant to poor prognosis in TNBC patients. SNRPC ablation significantly impaired the proliferation, migration and invasion of TNBC cells in vitro and in vivo. In addition, SNRPC was essential for the stability of U1 snRNP and contributed to the RNA Pol II-controlled transcription program. Knockdown of SNRPC decreased RNA Pol II enrichment on some oncogenes (TNFAIP2, E2F2 and CDK4) and reduced their expression levels. We further confirmed that SNRPC deletion would inhibit TNBC progression partially through the TNFAIP2-Rac1-β-catenin signal.

2023-03-15 | GSE227187 | GEO

In vivo CRISPR screen identifies SNRPC as a regulator for facilitating triple-negative breast cancer progression [ChIP-Seq]

2023-03-15 | GSE227185 | GEO

CRISPR RNA-seq from K562 (ENCSR840JRU)

Project description:RNA-seq on K562 cells treated with a CRISPR gRNA against SNRPC. (SNRPC-BGKcLV23) For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

2021-06-15 | GSE177916 | GEO

CRISPR RNA-seq from HepG2 (ENCSR005RUR)

Project description:RNA-seq on HepG2 cells treated with a CRISPR gRNA against SNRPC. (SNRPC-BGHcLV22) For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

2021-06-15 | GSE176618 | GEO

Homo sapiens

Project description:HMGA1: A master regulator of tumor progression in triple-negative breast cancer cells

| PRJNA194135 | ENA